PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#CMC ×

UPDATED
Regulatory Updates
Sep 28, 2026•1 min read
FDA Approves Manufacturing Supplements for LIORESAL (baclofen) Tablets
The FDA has approved a series of priority manufacturing (CMC) supplement submissions for the discontinued LIORESAL baclofen tablets (10 mg and 20 mg).
UPDATED
Regulatory Updates
Sep 27, 2026•1 min read
OCUCLEAR Ophthalmic Solution (0.025% OxyMetazoline HCl) Discontinued
OCUCLEAR ophthalmic drops containing 0.025% oxyMetazoline hydrochloride have been discontinued; FDA records show a series of approved manufacturing and labeling submissions from 1986 to 2001.